Please login to the form below

Not currently logged in
Email:
Password:

Purdue Pharma appoints Dr Craig Landau as its CEO

He also takes up president role

Craig Landau Purdue Pharma has appointed Dr Craig Landau as its new chief executive officer and president, roles that will see him be responsible for the firm’s US operations and retain responsibility for Purdue’s Canadian operations.

Landau first joined the Connecticut, US-based firm as president and CEO of Purdue Pharma Canada, he's spent the last three years diversifying and stabilising the business through a number of strategic business development deals.

He said: "I am honoured to be leading these organisations at such an exciting time.

"I look forward to building on Purdue’s rich history and working with my talented colleagues as we continue to broaden our portfolio and innovate to support healthcare professionals and serve patient needs.”

He succeeds Mark Timey who leaves Purdue Pharma to “pursue other career opportunities”.

29th June 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....

Infographics